Connect with us

Politics

‘We know what is coming’: Federal bureaucrats wrestle with fight-or-flight response to Trump election

Published

on

Thousands of federal bureaucrats have lived through one Donald Trump administration. Many are not sure they can or will survive a second.

Blue Light News spoke with more than a dozen civil servants, political appointees under President Joe Biden and recently departed Biden administration staffers in the days since the presidential election was called for Trump, who were granted anonymity due to the sensitivity of the topic and the risk to their jobs. Many are bracing for a wave of departures from key federal agencies in the coming months, amid fears that the next president will gut their budgets, reverse their policy agendas and target them individually if they do not show sufficient loyalty. The result is likely to be a sizable brain drain from the federal workforce — something Trump may welcome.

“Last time Trump was in office, we were all in survival mode with a hope for an end date,” said one State Department official. “Now there is no light at the end of the tunnel.”

The former president and his allies are deeply distrustful of the executive branch bureaucracy and the more than 2 million civil servants who staff it — blaming a federal “deep state” for trying to undermine him in his first term and driving the impeachment efforts against him. As president, Trump named political appointees to various agencies with the purpose of cleaning house — and will again have the chance to nominate people for roughly 4,000 political jobs throughout the administration. In 2021, his White House launched an effort to make it easier to fire civil servants and replace them with political appointees, something he is expected to restart when he returns in January. He’s also threatened to move thousands of federal jobs outside D.C.

Trump-Vance Transition spokesperson Karoline Leavitt did not reply directly to a query about the future of the federal workforce, saying, via email, “President-Elect Trump will begin making decisions on who will serve in his second Administration soon. Those decisions will be announced when they are made.”

Trump’s policy agenda is also at odds with core priorities for a number of agencies under Biden.

The former president and his allies are deeply distrustful of the executive branch bureaucracy and the more than 2 million civil servants who staff it.

Several of Biden’s political appointees at Department of Transportation headquarters near Washington’s Navy Yard were despondent at the prospect of a new Trump administration set on undoing much of their work over the past four years, including airline consumer protections and massive investments in infrastructure.

“There’s a lot of anxiety among Biden appointees, like myself, who need to find new jobs — and also among career staff who are worried about Trump trying to remove career civil servants who had a policymaking role,” a DOT official told Blue Light News.

“I am glad that I am retiring soon. … EPA is toast,” said a staffer at the Environmental Protection Agency, whose efforts to fight climate change clash with Trump’s “drill, baby, drill” approach to energy policy.

A number of officials, however, are wrestling with the conflicting desire to stay in government and defend the mission of the agencies they work for.

“We do our best to make sure either administration does what’s legal,” said a Department of Homeland Security staffer in a legal office. “If I leave, I’d be replaced with an enabler.”

The alarm over Trump’s return is particularly palpable among national security officials, environmental agencies and the federal health agencies, who fear the president-elect will follow through on his pledge to let noted vaccine skeptic Robert F. Kennedy Jr. “go wild on health.”

In his victory speech early Wednesday morning, Trump reiterated that promise. “He’s going to help make America healthy again. … He wants to do some things, and we’re going to let him get to it,” Trump said.

On Wednesday, Kennedy made the rounds on radio and television, saying that he would not seek to halt vaccinations.

Still, one current staffer at the National Institutes of Health said concerns are building inside the research agency about the future of vaccine research in the next administration.

NIH Director Monica Bertagnolli seemed to hint at those fears in an email sent to agency staff Wednesday that was shared with Blue Light News.

“With the 2024 election day now behind us, I want to acknowledge that change can leave us feeling uncertain,” she wrote.

“I do not want to dismiss those feelings, but I do want to remind everyone that throughout our 137-year history, the NIH mission has remained steadfast, and our staff committed to the important work of biomedical research in the service of public health.”

A former Food and Drug Administration official told Blue Light News on Wednesday that Kennedy’s assertions that he would have heavy influence over health agencies during Trump’s second term is raising the risk of career staff departing the agency responsible for drug oversight and food safety.

“The agency personnel are concerned, especially in light of Robert F. Kennedy Jr.’s statements and his potential role at the agency,” said the former official. “The reality of that is something the agency has to grapple with.”

A former FDA official told POLITICO on Wednesday that Kennedy's assertions that he would have heavy influence over health agencies during Trump's second term is raising the risk of career staff departing the agency responsible for drug oversight and food safety.

“They’re worried, they’ve been through transitions before so they clearly understand how to do that, but they read the news, the same as you and me,” said a separate former senior FDA official. “I think it’s a lot of RFK-driven stuff.”

Staffers at the Centers for Disease Control and Prevention also fear that under Trump, the public health agency — so central to the Covid-19 response — has “a target on its back,” as one person who works with the agency said.

Republicans have outlined clear plans for changes to the CDC — including the Heritage Foundation’s Project 2025, which includes ambitions to split the agency into two. (The Trump campaign has insisted that Project 2025 isn’t its official policy.) And many conservatives, including Trump’s former FDA commissioner, have argued that the CDC should narrow its scope to focus mainly on disease control.

“What is very clear is that in 2016, Trump was completely unprepared, and now he has a plan, and public health is right smack in the middle of it,” the person said.

A national security analyst who recently left the Biden administration shared similar fears and said having lived through a previous Trump administration, many civil servants are even more wary of working for a second one.

“People are sad and frightened. And what makes it worse is this time we know what is coming. It isn’t theoretical. It is real,” the analyst said.

“At State in particular, it is going hard to overstate how targeted people, career officers will be,” they said. “There will be no grace.”

Not everyone shared that bleak outlook. “I actually don’t see the freak-out yet, maybe it will come when the transition begins in earnest, but the folks I’ve talked to seem to have a pretty sober take that Trump’s victory means we carry out his policies,” said another State Department official. “If people disagree with those policies, nobody will hold anything against anyone that opts to leave.”

One Health and Human Services official who has worked under both Republican and Democratic administrations told Blue Light News that while individual employees are freaking out about the election results, the overall vibe of her office this week is: “Business as usual. Keep on working. It is what it is.”

She is trying to find a glimmer of hope in the Trump administration’s mixed record on health care.

“There are sometimes weird synergies,” she said. “Like under the first Trump administration, Scott Gottlieb was a very strong tobacco control advocate, and the Center for Tobacco Products was actually able to do more than they could under the Obama administration.”

“So I’m asking myself: Are there pathways to work with people that you disagree with and despise?”

Michael Doyle, Kevin Bogardus and Hannah Northey contributed to this report.

Continue Reading

Politics

Chuck Schumer gets his preferred candidate, Janet Mills, in crowded Maine Senate race

Published

on

Maine Gov. Janet Mills joined her state’s crowded Democratic Senate primary as the establishment favorite on Tuesday, aiming to flip Republican Sen. Susan Collins’ seat in a pivotal midterm year.

Democrats view the seat as one of their top pickup opportunities — the only in a state Kamala Harris won in 2024 — and Mills is among a few top-tier candidates Senate Minority Leader Chuck Schumer aggressively recruited to run this cycle. But first the term-limited governor must contend with a competitive primary against breakout candidate Graham Platner, an oyster farmer who announced he has more than $3 million in the bank and already received the endorsement of Sen. Bernie Sanders (I-Vt.).

Maine Beer Company owner Dan Kleban is also running for the nomination and his fundraising figures will be made public Wednesday, when federal filings are released.

In her launch video, Mills highlighted her recent fight with President Donald Trump over transgender sports and accused Collins of enabling him. “I won’t sit idly by while Maine people suffer and politicians like Susan Collins bend the knee as if this were normal,” Mills said.

Despite initial hesitation, the governor started interviewing staff and telling local reporters she was seriously considering a bid last month.

She addressed that long contemplation in her announcement, saying in the video, “Honestly, if this president and this Congress were doing things that were even remotely acceptable, I wouldn’t be running for the U.S. Senate.”

The race sets up the latest generational clash for a party struggling to find its footing after losing the White House and both branches of Congress last year.

Mills, who won her seat by wide margins in her last two races, is 77 years old, making her five years Collins’ senior at a time when Americans are grappling with debates about the age of their politicians. If elected, she would be the oldest first-year senator ever. Platner is 41 and unlikely to leave the race for Mills; Kleban, who is 48, has so far dodged questions about what he would do if Mills jumped in.

Democrats need to pick up four seats in order to win back control of the Senate, a difficult task that all but has to include a pickup in Maine, where Harris won by 7 points.

Democrats poured millions of dollars into an ultimately-unsuccessful effort to unseat Collins in 2020 — but her declining popularity in the bluing state is giving Democrats hope that next year’s race could be their best chance yet.

Republicans are eager to expose Mills’ weaknesses, and have already targeted her public fight Trump, as well as her age.

Continue Reading

Politics

‘He hasn’t surrendered yet’: Chuck Schumer’s critics are satisfied — for now

Published

on

‘He hasn’t surrendered yet’: Chuck Schumer’s critics are satisfied — for now

The guardedly positive reviews for the New Yorker’s leadership come as the shutdown fight enters a politically perilous new phase…
Read More

Continue Reading

Politics

Sen. Mark Kelly says vote on healthcare subsidies alone won’t end shutdown

Published

on

Sen. Mark Kelly says vote on healthcare subsidies alone won’t end shutdown

The Arizona Democrat said there must be an actual fix…
Read More

Continue Reading

Trending